Jasper Therapeutics Inc (JSPR)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.18M
Last updated: Nov 17, 2026 at 4:10 PM ET
Jasper Therapeutics Inc (JSPR) Stock Chart
Jasper Therapeutics (JSPR) has a latest price of $10.34 on Nov 17, 2026, 83.3% below its 52-week high of $62.10. Its price fell 79.5% over the past 12 months. The month-end price fell 99.4% over the 5 years through Oct 2026, a compound annual decline of 64.4%.
Price Chart
From Sep 2021 to Oct 2026, its highest month-end close was $3,081.08 in Sep 2021 and its lowest $12.64 in Jun 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart JSPR with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JSPR.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 53.8%, and over 6 months it fell 57.9%. The month-end price fell 92.1% over the 3 years through Oct 2026, a compound annual decline of 57.1%.
| Period | Change |
|---|---|
| 1 month | -27.8% |
| 3 months | -53.8% |
| 6 months | -57.9% |
| 12 months | -79.5% |
| 12 months, with dividends | -79.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -92.1% | -57.1% |
| 5 years | -99.4% | -64.4% |
Price by Year
Its best calendar year was 2024, when the price rose 171.0%, and its weakest was 2022, when it fell 93.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $15.62 | -71.6% |
| 2025 | $54.95 | -91.4% |
| 2024 | $642.04 | +171.0% |
| 2023 | $236.94 | +63.4% |
| 2022 | $145.01 | -93.8% |
Trading Range
The price is 36.9% below its 50-day average of $16.38 and 56.2% below its 200-day average of $23.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $10.34 | |
| 52-week high | $62.10 | -83.3% |
| 52-week low | $9.45 | +9.4% |
| 50-day average | $16.38 | -36.9% |
| 200-day average | $23.63 | -56.2% |
Price Risk
Over 3 years, its largest fall from a peak was 98.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.82 |
| Largest fall, 1 year | -83.4% |
| Largest fall, 3 years | -98.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About JSPR
What is JSPR's 1-year price change?
Jasper Therapeutics's price fell 79.5% over the past 12 months. With dividends included, the 12-month total return was -79.5%.
What is JSPR's 5-year price change?
Jasper Therapeutics's month-end price fell 99.4% over the 5 years through Oct 2026, a compound annual decline of 64.4%. These figures leave out dividends.
What is JSPR's 52-week high and low?
Jasper Therapeutics's 52-week high is $62.10 and its 52-week low is $9.45. Its latest price of $10.34 on Nov 17, 2026 is 83.3% below the high.
What is JSPR's beta?
Jasper Therapeutics's 1-year beta against the S&P 500 is 1.82, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 83.4%.
Is the JSPR chart free?
Yes. Advanced Charting for JSPR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
JSPR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors